Tower Research Capital (TRC)’s Candel Therapeutics CADL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $48.6K | Buy |
9,608
+7,527
| +362% | +$38.1K | ﹤0.01% | 2993 |
|
|
2025
Q1 | $11.8K | Buy |
2,081
+624
| +43% | +$3.53K | ﹤0.01% | 3508 |
|
|
2024
Q4 | $12.6K | Sell |
1,457
-1,279
| -47% | -$11.1K | ﹤0.01% | 3598 |
|
|
2024
Q3 | $19K | Buy |
2,736
+1,484
| +119% | +$10.3K | ﹤0.01% | 3268 |
|
|
2024
Q2 | $7.76K | Sell |
1,252
-2,450
| -66% | -$15.2K | ﹤0.01% | 4428 |
|
|
2024
Q1 | $5.85K | Sell |
3,702
-3,031
| -45% | -$4.79K | ﹤0.01% | 4478 |
|
|
2023
Q4 | $9.9K | Sell |
6,733
-1,914
| -22% | -$2.81K | ﹤0.01% | 4331 |
|
|
2023
Q3 | $7.96K | Buy |
8,647
+385
| +5% | +$354 | ﹤0.01% | 4416 |
|
|
2023
Q2 | $10.4K | Buy |
8,262
+1,686
| +26% | +$2.12K | ﹤0.01% | 4102 |
|
|
2023
Q1 | $9K | Sell |
6,576
-638
| -9% | -$873 | ﹤0.01% | 4469 |
|
|
2022
Q4 | $13K | Buy |
7,214
+3,077
| +74% | +$5.55K | ﹤0.01% | 3582 |
|
|
2022
Q3 | $13K | Buy |
4,137
+2,918
| +239% | +$9.17K | ﹤0.01% | 4259 |
|
|
2022
Q2 | $4K | Buy |
1,219
+1,165
| +2,157% | +$3.82K | ﹤0.01% | 5175 |
|
|
2022
Q1 | $0 | Buy |
+54
| New | – | ﹤0.01% | 6112 |
|